No Data
wuhan easy diagnosis biomedicine (002932.SZ): has repurchased 3.61% of the shares.
On September 2nd, Gelonghui announced that as of August 31st, 2024, Wuhan Easy Diagnosis Biomedicine (002932.SZ) repurchased 8,398,718 shares of the company's stock through a repurchase dedicated securities account through centralized bidding, accounting for 3.61% of the company's total share capital; The highest fill price for repurchased shares was RMB 20.98 per share, and the lowest fill price was RMB 16.35 per share, with a total fill amount of RMB 1.64 billion (excluding trading fees).
Matilda Biotech: 2024 Semi-Annual Report
Matilda Biotech: 2024 Semi-Annual Report Summary
Wuhan Easy Diagnosis Biomedicine (002932.SZ) announced its performance for the first half of the year, with a net income of 65.1626 million yuan, a decrease of 42.12%.
Wuhan Easy Diagnosis Biomedicine (002932.SZ) released its 2024 interim report, with revenue for the reporting period...
As of August 9, 2024, Wuhan Easy Diagnosis Biomedicine (002932.SZ) has a total of 32,326 shareholders.
Wuhan Easy Diagnosis Biomedicine (002932.SZ) stated on the investor interaction platform on August 14th that as of August 9th, 2024, the total number of shareholders in the company was 32,326.
Wuhan Easy Diagnosis Biomedicine (002932.SZ): The actual controller has been changed from Chen Lili and Wang Ying to Chen Lili.
On August 13th, Gelunhui reported that Wuhan Easy Diagnosis Biomedicine (002932.SZ) recently received notice from the actual controllers, Ms. Chen Lili and Ms. Wang Ying (referred to as the "original actual controllers" or "both parties"), regarding the expiration of the Joint Action Agreement and the non-renewal thereof. Since the Joint Action Agreement signed by the original actual controllers on August 11, 2021, has expired on August 10, 2024, both parties have agreed not to renew the Joint Action Agreement after friendly consultation. The joint action relationship between the original actual controllers mentioned above will end on August 10, 2024. The termination of the joint action relationship between both parties this time will
No Data
No Data